# Double Blind Study of Trp01 in Patients With Alzheimer's Disease

> **NCT00202124** · PHASE4 · COMPLETED · sponsor: **Queen's University** · enrollment: 12 (—)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Tryptophan

## Key facts

- **NCT ID:** NCT00202124
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** 12 (—)
- **Last updated:** 2005-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202124, "Double Blind Study of Trp01 in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00202124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*